Bladder Cancer,Genitourinary Cancer Subcutaneous Fat Area as Parastomal Hernia Risk: PUBMIC Trial Data Jan 08, 2024
Bladder Cancer,Genitourinary Cancer Erdafitinib in BCG-Resistant HR NMIBC With FGFR Mutations Dec 20, 2023
Bladder Cancer,Genitourinary Cancer Real-World Use of Avelumab Maintenance in Advanced UC Patients Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Erdafitinib vs. Pembrolizumab in Advanced UC With FGFR Alterations Dec 14, 2023
Bladder Cancer,Genitourinary Cancer Nadofaragene Firadenovec Efficacy in BCG-unresponsive NMIBC With CIS Dec 08, 2023
Bladder Cancer,Genitourinary Cancer NIVO+ GC Extends Survival in Advanced Urothelial Carcinoma Dec 07, 2023
